Browsing by Author Sampol, Antonia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 4 to 10 of 10 < previous 
Issue DateTitleAuthor(s)
2-Nov-2023Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myelomaRosiñol, Laura; Oriol, Albert; Rios, Rafael; Blanchard, Maria Jesús; Jarque, Isidro; Bargay, Juan; Hernández, Miguel Teodoro; Cabanas, Valentín; Carrillo Cruz, Estrella; Sureda, Anna; Martínez López, Joaquín; Krsnik, Isabel; González, María Esther; Casado, Luís Felipe; Martí, Josep Maria; Encinas, Cristina; Arriba, Felipe de; Palomera, Luis; Sampol, Antonia; Gonzalez Montes, Yolanda; Cabezudo, Elena; Paiva, Bruno; Puig, Noemí; Cedena, Maria Teresa; Cruz, Javier de la; Mateos, María Victoria; San Miguel, Jesús; Lahuerta, Juan José; Bladé, J. (Joan)
Oct-2014Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantationVallejo, Carlos; Batlle, Montserrat; Vazquez, Lourdes; Solano, Carlos; Sampol, Antonia; Duarte, Rafael; Hernández, Dolores; López, Javier; Rovira Tarrats, Montserrat; Jiménez, Santiago; Valcárcel, David; Belloch, Vicente; Jiménez, Mónica; Jarque, Isidro; Subcommittee of Non-Infectious Complications of the Grupo Español de Trasplante Hematopoyético (GETH)
1-Jan-2022Post-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TCBailén, Rebeca; Pascual Cascón, María Jesús; Guerreiro, Manuel; López Corral, Lucía; Chinea, Anabelle; Bermúdez, Arancha; Sampol, Antonia; Heras, Inmaculada; García Torres, Estefanía; Torres, Melissa; Rifón Roca, José; Herruzo, Beatriz; Sanz, Jaime; Fonseca, Marta; Herrera, Pilar; Colorado, Mercedes; Bento, Leyre; López Godino, Oriana; Martín Calvo, Carmen; Fernández Caldas, Paula; Marcos Jubilar, María; Sánchez Ortega, Isabel; Solano, Carlos; Noriega, Víctor; Humala, Karem; Oarbeascoa, Gillen; Díez Martín, José Luis; Kwon, Mi
13-Sep-2021Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1Oñate, Guadalupe; Bataller, Alex; Garrido, Ana; Hoyos Colell, Montserrat; Arnan, Montserrat; Vives, Susana; Coll, Rosa; Tormo, Mar; Sampol, Antonia; Escoda, Lourdes; Salamero, Olga; Garcia, Antoni; Bargay, Joan; Aljarilla, Alba; Nomdedeu, Josep F.; Esteve, Jordi; Sierra, Jorge; Pratcorona, Marta
2-Oct-2015The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaDíaz Beyà, Marina; Brunet, Salut; Nomdedéu Guinot, Josep Francesc; Cordeiro Santanach, Anna; Tormo, Mar; Escoda, Lourdes; Ribera, Josep Maria; Heras, Inmaculada; Gallardo Giralt, David; Bargay, Joan; Queipo de Llano, María Paz; Salamero, Olga; Martí, Josep María; Sampol, Antonia; Pedro, Carme; Hoyos Colell, Montserrat; Pratcorona, Marta; Castellano, Joan Josep; Nomdedeu i Fàbrega, Meritxell; Risueño, Ruth M.; Sierra Gil, Jorge; Monzó Planella, Mariano; Navarro Ponz, Alfons; Esteve Reyner, Jordi; Arnan, Montserrat
16-Oct-2015The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell TransplantationNoriega, Victor; Martínez-Laperche, Carolina; Buces, Elena; Pion, Marjorie; Sánchez-Hernández, Noemí; Martín-Antonio, Beatriz; Guillem, Vicent; Bosch-Vizcaya, Anna; Bento, Leyre; González Rivera, Milagros; Balsalobre, Pascual; Kwon, Mi; Serrano, David; Gayoso, Jorge; Cámara, Rafael de la; Brunet, Salut; Rojas-Contreras, Rafael; Nieto, José B.; Martínez, Carmen; Gónzalez, Marcos; Espigado, Ildefonso; Vallejo, Carlos; Sampol, Antonia; Jiménez-Velasco, Antonio; Urbano Ispizua, Álvaro; Solano, Carlos; Gallardo, David; Díez-Martín, José L.; Buño, Ismael; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
11-Sep-2015The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signatureDíaz Beyà, Marina; Brunet, Salut; Nomdedéu Guinot, Josep Francesc; Pratcorona, Marta; Cordeiro Santanach, Anna; Gallardo Giralt, David; Escoda, Lourdes; Tormo, Mar; Heras, Inmaculada; Ribera, Josep Maria; Duarte, Rafael; Queipo de Llano, María Paz; Bargay, Joan; Sampol, Antonia; Nomdedeu i Fàbrega, Meritxell; Risueño, Ruth M.; Hoyos Colell, Montserrat; Sierra Gil, Jorge; Monzó Planella, Mariano; Navarro Ponz, Alfons; Esteve Reyner, Jordi